Medical News

RSS

Human amniotic fluid skin cells "reprogrammed" to pluripotency

In a breakthrough that may help fill a critical need in stem cell research and patient care, researchers at Mount Sinai School of Medicine have demonstrated that skin cells found in human amniotic fluid can be efficiently "reprogrammed" to pluripotency, where they have characteristics similar to human embryonic stem cells that can develop into almost any type of cell in the human body. The study is online now and will appear in print in the next issue of the journal Cellular Reprogramming, to be published next month.

16 Mar 2010

Varian Medical Systems chooses EasyLink as provider for hosted fax services

EasyLink Services International Corporation, a premier global provider of comprehensive messaging services and e-commerce solutions, announced today that Varian Medical Systems has selected EasyLink as its provider for hosted fax services for an initial three-year term.

16 Mar 2010

External beam radiotherapy device without shielded bunker infrastructure for breast cancer irradiation

Orbital Therapy has completed the build of their proof-of-concept prototype for breast cancer irradiation, and demonstrated the feasibility to develop and operate an external beam radiotherapy device without the use of a heavily shielded bunker infrastructure.

16 Mar 2010

Seatac Digital Resources provides $1.5M bridge financing commitment to AMHN

AMHN, Inc., parent company of America's Minority Health Network, Inc., announced bridge financing commitments in the aggregate of $1.5 million provided by one of its majority shareholders and vendors, Seatac Digital Resources, Inc., a Delaware corporation.

16 Mar 2010

Actoplus Met and Actos: Mylan enters into settlement agreements with Takeda Pharmaceutical

Mylan Inc. today announced that it has entered into settlement agreements with Takeda Pharmaceutical Co. related to two treatments for type 2 diabetes: Actoplus Met®, 15 mg/500 mg and 15 mg/850 mg, known generically as Pioglitazone Hydrochloride (HCl) and Metformin HCl Tablets, and Actos®, 15 mg, 30 mg and 45 mg, known generically as Pioglitazone HCl Tablets.

16 Mar 2010

WebMD Health increases pricing of tender offer for common stock to $46.80 per share

WebMD Health Corp. announced today that it is increasing the price in the pending tender offer for its common stock to $46.80 per share. The number of shares proposed to be purchased in the tender offer is, as previously announced, 5,800,000, representing approximately 11% of WebMD's currently outstanding shares.

16 Mar 2010

EMSI selects SmartDog Services for Oracle eBusiness Suite support through ZDA

SmartDog Services, LLC, a leading provider of services for the Oracle community is pleased to introduce its new client, Examination Management Services, Inc. (EMSI).

16 Mar 2010

Adam 3XL addresses young people with weight problem

Adam 3XL (published by Trafford) by Dr. Martin Noelke is a novel about basketball, love, friendship ... and some nutritional guidelines for weight reduction in the long run. It's the story of a one-time high school basketball all-star who stops exercising and packs on the pounds after losing both of his parents. Dr. Noelke infuses his expertise as a general practitioner and nutrition specialist into the story to send a message to today's youth about health.

16 Mar 2010

Optics Balzers acquires mso jena Mikroschichtoptik

Optics Balzers, a leading supplier of innovative optical thin-film components and assemblies, is continuing its growth in great strides. With its acquisition of “mso jena Mikroschichtoptik GmbH” in Jena, Germany, it is expanding its competencies and manufacturing technologies into a unique portfolio.

16 Mar 2010

CareTech Solutions signs five-year infrastructure outsourcing contract with Sibley Memorial Hospital

CareTech Solutions, Inc., (www.caretech.com) an information technology (IT) and Web products and services company servicing U.S. hospitals and health systems, announced today that it has signed a five-year, comprehensive infrastructure outsourcing contract with Sibley Memorial Hospital, a full-service, 328 bed nonprofit acute care community hospital serving the Washington, D.C. area.

16 Mar 2010

PCI Biotech completes treatment of third dose group in phase I/II study of Amphinex in cancer patients

PCI Biotech reported today that it has completed the treatment of the third dose group in the phase I/II study of its proprietary photosensitiser Amphinex® used in combination with the cytotoxic agent bleomycin in cancer patients.

16 Mar 2010

LUMC purchases Fluidigm Access Array system

Fluidigm Corporation and BIOKÉ, distributor of Fluidigm systems in the Benelux, today announced that Leiden University Medical Center’s (LUMC) Human Genetics Department has purchased a Fluidigm Access Array™ system. The Access Array system enables users to automatically prepare sequencing-ready libraries from up to 48 individual samples at a time, for as little as €7 (EUR) per sample.

16 Mar 2010

Sigma-Aldrich signs agreement to acquire Ace Animals

Sigma-Aldrich® today announced it has signed an agreement to acquire Ace Animals, Inc., a Berks County, PA.-based provider of high quality research rodents to the biomedical industry.

16 Mar 2010

Tolerx publishes follow-up data from study of otelixizumab therapy for new onset T1DM patients

Tolerx, Inc., today announced the publication in Diabetologia, the journal of the European Association for the Study of Diabetes, of the four-year follow-up clinical data from new onset type 1 diabetes (T1DM) patients (age 12-39) who received a single short course of therapy with otelixizumab (ChAglyCD3).

16 Mar 2010

The Beryl Institute joins with Sodexo to release white paper focusing patient-centered environment

The Beryl Institute, an organization dedicated to improving customer service in healthcare, has combined efforts with Sodexo, Inc., a leading integrated food and facilities management services company in North America, to release its latest white paper, “Perspectives on a Patient-Centered Environment.”

16 Mar 2010

NextGen Healthcare Information Systems executes agreement with WSUPG to deploy NextGen Practice Solutions

NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc. and leading provider of healthcare information systems and connectivity solutions, today announced it has executed an agreement with Wayne State University Physician Group to deploy NextGenSM Practice Solutions, a line of business devoted to providing healthcare organizations with cost-effective revenue cycle management (RCM) services.

16 Mar 2010

Lantheus Medical Imaging announces preliminary data on flurpiridaz F 18 PET MPI agent

Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic imaging, today announced preliminary data on flurpiridaz F 18 (formerly known as BMS747158), its novel compound in development as a Positron Emission Tomography (PET) myocardial perfusion imaging (MPI) agent. The study of nine patients compared rest-stress flurpiridaz F 18 PET MPI, with rest-stress technetium-99m (Tc-99m) labeled single photon emission computed tomography (SPECT) for the detection and evaluation of coronary artery disease (CAD).

16 Mar 2010

Patient enrollment in Spinal Restoration' Phase III study of Biostat System now underway

Spinal Restoration, Inc. announced today that patient enrollment in the company’s Phase III study of the Biostat System for the treatment of discogenic chronic low back pain is now underway. The study, which will be conducted at 15 U.S. clinical sites, is one of only a few multi-center, randomized, blinded, placebo-controlled trials of a nonsurgical treatment for discogenic low back pain ever to be conducted.

16 Mar 2010

Mission Pharmacal, March of Dimes to distribute healthy pregnancy, healthy baby education materials

Mission Pharmacal announced today that it will partner with the March of Dimes to distribute healthy pregnancy and healthy baby education materials to more than 15,000 obstetricians and gynecologists nationwide to help more babies be born healthy.

16 Mar 2010

Blocking RhoA enzyme increases survival in SMA mouse model

Scientists from the Ottawa Hospital Research Institute (OHRI) and the University of Ottawa have identified a promising new approach for developing drugs to treat Spinal muscular atrophy (SMA), the leading inherited cause of death in infants and toddlers. Dr. Rashmi Kothary and his doctoral student Melissa Bowerman have found that an enzyme called RhoA is overly active in a mouse model of the disease and blocking this enzyme can greatly increase survival. The study is published in Human Molecular Genetics.

16 Mar 2010

Medical News

Human amniotic fluid skin cells "reprogrammed" to pluripotency

Varian Medical Systems chooses EasyLink as provider for hosted fax services

External beam radiotherapy device without shielded bunker infrastructure for breast cancer irradiation

Seatac Digital Resources provides $1.5M bridge financing commitment to AMHN

Actoplus Met and Actos: Mylan enters into settlement agreements with Takeda Pharmaceutical

WebMD Health increases pricing of tender offer for common stock to $46.80 per share

EMSI selects SmartDog Services for Oracle eBusiness Suite support through ZDA

Adam 3XL addresses young people with weight problem

Optics Balzers acquires mso jena Mikroschichtoptik

CareTech Solutions signs five-year infrastructure outsourcing contract with Sibley Memorial Hospital

PCI Biotech completes treatment of third dose group in phase I/II study of Amphinex in cancer patients

LUMC purchases Fluidigm Access Array system

Sigma-Aldrich signs agreement to acquire Ace Animals

Tolerx publishes follow-up data from study of otelixizumab therapy for new onset T1DM patients

The Beryl Institute joins with Sodexo to release white paper focusing patient-centered environment

NextGen Healthcare Information Systems executes agreement with WSUPG to deploy NextGen Practice Solutions

Lantheus Medical Imaging announces preliminary data on flurpiridaz F 18 PET MPI agent

Patient enrollment in Spinal Restoration' Phase III study of Biostat System now underway

Mission Pharmacal, March of Dimes to distribute healthy pregnancy, healthy baby education materials

Blocking RhoA enzyme increases survival in SMA mouse model

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Latest News